← Back to trade feed
HALO Sell (partial)
Gilbert CisnerosDemocrat · CA-31 · HouseTraded Sep 29, 2026Notified Oct 9, 2026
Trade details
| Amount | $1,001 – $15,000 |
| Asset | Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST] (ST) |
| Issuer | HALOZYME THERAPEUTICS, INC. |
| Disclosure | 2026 PTR |
What happened next
Stock performance after the trade and after the disclosure became public, compared with SPY, an S&P 500 ETF.
Historical market data is not connected yet.
Conflict Score
0
No mapped overlap
Committee–industry overlap. The explanation and original filing are available below.
Why this score
- No oversight overlap was identified between Rep. Gilbert Cisneros (D-CA) and Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST].
- The member's committee jurisdictions do not map to the traded issuer's sector or specific oversight domains.
Powered by the base rules engine. Modifiers (trade size, timing, owner, options) are layered in a later release.
What do the scores mean? Committee–industry overlap
- 65
- Direct jurisdiction
- 50
- Subcommittee
- 30
- Sector overlap
- 18
- Broad jurisdiction
- 0
- No mapped overlap
- —
- Not scored · missing data
The current base model tops out at 65 on a reserved 0–100 scale. Scores are not probabilities or findings of wrongdoing. Zero means no overlap in our mapping, not an absence of all possible conflicts. Read the methodology →
Original extracted asset text
Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST]
Extraction may include form headers. The linked original filing is authoritative.